S 3510 · 119th CongressIn Committeecongress.gov ↗

Biosimilar Inspection Modernization Act of 2025

Share Share Share

What this bill does

AI plain-language summary

This bill appears to deal with updating or changing how inspections are carried out for biosimilar products, which are medicines that are very similar to brand-name biological drugs. No official summary is available for this bill.

Sponsor

Sen. Budd, Ted [R-NC]

R

Introduced

December 16, 2025

Policy Area

Health

Your Vote

Discussion (0)

Explain what is at stake in this bill.

Sign in to join the discussion.

No comments yet. Be the first.